Table 1 Demographics and baseline characteristics of COVID-19 patients
From: Beware of pharyngeal Fusobacterium nucleatum in COVID-19
|
Pharyngeal swab samples (n = 28) |
Fecal samples (n = 36) | |
|---|---|---|
| Age (yrs) - medium (IQR) | 36.0 (28 ~ 49.5) | 46.5 (34.3 ~ 56.0) |
| Age groups – No. (%) | ||
| ≤ 30 yrs | 11 (39.29) | 8 (22.22) |
| 31 ~ 50 yrs | 10 (35.71) | 15 (41.67) |
| >50 yrs | 7 (25.00) | 13 (36.11) |
| Sex – No. (%) | ||
| Male | 20 (71.43) | 18 (50) |
| Female | 8 (28.67) | 18 (50) |
| Severity of illness – No. (%) | ||
| Asymptomatic infection | 4 (14.29) | 3 (8.33) |
| Mild illness | 4 (14.29) | 4 (11.11) |
| Moderate illness | 20 (71.43) | 24 (66.67) |
| Severe illness | 0 | 5 (13.89) |
| Sampling intervals a –No. (%) | ||
| ≤ 7 d | 23 (85.2) | 9 (26.5) |
| > 7 d | 4 (14.8) | 25 (73.5) |
| SARS-CoV-2 RNA detection (%) | ||
| Positive (+) | 28 (100) | 26 (72.22) |
| Negative (−) | 0 (0) | 10 (27.78) |